Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CLSN

Imunon (CLSN) Stock Price, News & Analysis

Imunon logo

About Imunon Stock (NASDAQ:CLSN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$1.95
$2.63
52-Week Range
N/A
Volume
711 shs
Average Volume
150,471 shs
Market Capitalization
$13.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CLSN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Imunon and its competitors with MarketBeat's FREE daily newsletter.

CLSN Stock News Headlines

Imunon Inc IMNN
CLSN.L Regulatory News
Here's the last trade you should make before heading out for the weekend tomorrow.
Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.
See More Headlines

CLSN Stock Analysis - Frequently Asked Questions

Imunon, Inc. (NASDAQ:CLSN) released its quarterly earnings data on Monday, August, 15th. The biotechnology company reported ($0.87) earnings per share for the quarter, beating the consensus estimate of ($1.12) by $0.25. Imunon had a negative trailing twelve-month return on equity of 50.18% and a negative net margin of 5,229.80%.

Shares of Imunon reverse split on Tuesday, March 1st 2022.The 1-15 reverse split was announced on Tuesday, March 1st 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, March 1st 2022. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Imunon investors own include Tonix Pharmaceuticals (TNXP), Tesla (TSLA), Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX), Acasti Pharma (ACST), Corbus Pharmaceuticals (CRBP) and Dynavax Technologies (DVAX).

Company Calendar

Last Earnings
8/15/2022
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CLSN
CIK
749647
Employees
27
Year Founded
1982

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$20.77 million
Net Margins
-5,229.80%
Pretax Margin
-5,506.60%
Return on Equity
-50.18%
Return on Assets
-36.94%

Debt

Debt-to-Equity Ratio
0.13
Current Ratio
6.52
Quick Ratio
6.52

Sales & Book Value

Annual Sales
$500 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$9.66 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
7,099,000
Free Float
6,768,000
Market Cap
$13.91 million
Optionable
Optionable
Beta
2.27

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:CLSN) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners